首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
对379例良、恶性肝组织进行的免疫组织化学研究显示,33%的慢性迁延性肝炎(6/18)、76%的慢性活动性肝炎(26/34)、92%的肝硬变(57/62)和97%的肝细胞性肝癌(HCC)(58/60)中有HBxAg表达,阳性率高于HBsAg或HBcAg。癌周肝中的HBxAg阳性率显著高于非癌周肝。与其它2种HBV抗原不同,HBxAg表达在细胞类型上有较明显的选择性,在肝小多角细胞(SPLC)、小细胞性不典型增生(SCD)及HCC中较强。与IGFⅡ、c-erbB-2、c-myc和EGF-R表达进行的对照研究表明HBxAg与IGFⅡ和c-erbB-2这2种HCC发生相关基因的表达关系密切。PCNA染色结果显示HBxAg阳性组织的细胞增殖活性显著高于HBxAg阴性组织。我们的结果还表明HBxAg表达与肝细胞不典型增生的发生和进展有关、提出HBVX基因可能通过其表达产物(HBxAg)首先激活IGFⅡ、c-erbB-2基因,继而引起显著的SPLC增生和SCD而参与HCC发生的.  相似文献   

2.
为了明确N-ras、c-myc癌基因在人肝细胞癌(HCC)中的表达及其形态学分布,我们对38例石蜡包埋的HCC(其中33例带有癌周肝组织)标本进行了原位核酸杂交和免疫组化研究。结果表明,HCC及癌周肝组织中N-ras表达阳性率分别为42%和39%;c-mycmRNA阳性表达率分别为47%和36%;c-myc蛋白阳性率分别为53%和39%。HCC与癌周肝之间N-ras、c-mycmRNA及c-myc蛋白表达水平无显著差别;c-mycmRNA及蛋白阳性强度也无显著差别,其形态学分布基本一致,主要集中于癌细胞和癌周肝中的部分高度增生结节;N-ras表达增强主要见于癌细胞、癌周肝中的高度增生结节、小细胞性不典型增生及少部分肝小多角细胞。它们与HBxAg表达之间无明确的对应关系。上述结果显示,HCC中N-ras、c-myc表达都显著增强,它们可能是人HCC发生中较晚期的事件,而N-ras表达增强早于c-myc癌基因活化。  相似文献   

3.
原位杂交检测石蜡包埋组织中丙型肝炎病毒RNA   总被引:2,自引:0,他引:2  
为了提高HCVRNA的原位杂交检出率,我们应用地高辛标记HCV5'非编码区cDNA作探针,采用原位分子杂交法对96N肝硬变,102例肝细胞肝癌进行了HCVRNA检测,并结合不同年份标本中HCVRNA的检出率,探讨HCVRNA在肝脏的分布及其丢失问题.结果显示HCVRNA定位于肝细胞和肝癌细胞胞浆内,肝脏其它细胞未见明确阳性杂交信号。HCVRNA杂交阳性细胞呈灶状和弥漫分布,正常对照、替代、空白对照为阴性,在不同年份肝硬变及肝细胞肝癌中两两比较表明新近包埋蜡块组织较陈旧蜡块组织HCV RNA检出率明显高。本文结果证实HCVRNA存在于肝细胞和癌细胞的胞浆内,未见肝内其它细胞阳性,还发现HCVRNA在肝硬变、肝细胞癌中的检出率随保存时间的延长,其阳性检出率明显降低,表明HCVRNA在蜡块中存在明显的降解,应尽可能选用近期标本、为临床分析HCV感染,HCV与肝硬变、肝细胞肝癌的关系提供更客观的数据。  相似文献   

4.
利用图像分析技术对轻度慢性活动性肝炎(MCAH)、重度慢性活动性肝炎(SCAH)、小结节肝硬变(MINC)、大结节肝硬变(MANC)、癌周肝硬变(PC)和肝细胞癌(HCC)及正常对照共67例样本的肝细胞或癌细胞DNA含量进行测定分析。结果(1)MCAH、SCAH和MANC多倍体化受抑制,显示细胞分化能力下降,可能与肝癌的发生相关;(2)HCC均为异倍体肿瘤,细胞具有较高的增殖能力并处于较低的分化状态;(3)PC倍体分布和双核细胞率介于其他非癌病变和HCC之间,细胞分化受抑制且有向异倍体发展趋势,具有癌前病变性质;(4)MINC明显多倍体化,为分化性的再生修复病变而与肝癌发生无关。因此肝细胞DNA含量的定量分析对于了解肝细胞的增生状态,以及患者的预后评估有重要意义。  相似文献   

5.
本研究应用ABC免疫组化技术显示,奶油黄、液氮致局部冻伤及CCl_4所致的三种肝损伤中也有细胞角蛋白(CK)异常表达肝细胞。(1)在局部肝冻伤及奶油黄性肝损伤中表明不伴脂肪变性的肝细胞坏死不能直接引起肝细胞CK表达的改变;(2)在奶油黄性肝损伤中显示了卵圆细胞对肝细胞CK异常表达的诱导作用,表明层粘连蛋白(LN)可能是这种作用的媒介;(3)在CCl_4致慢性肝损伤中表明肝细胞CK异常表达和LN异常沉积无论在位相上还是在时相上都一致,提出肝小叶结构破坏可能也是通过LN异常沉积而影响肝细胞的CK表达;(4)应用电镜及免疫电镜技术表明CCl_4性肝损伤中肝细胞中间丝细胞骨架结构的改变伴随着CK19阳性抗原决定簇的出现;(5)设计了一种局部肝冻伤模型,利用这种模型表明,CK19阳性肝细胞在肝小叶结构完整性遭到破坏且伴纤维组织增生时出现,随小叶结构的恢复而消失。这是对关于肝细胞CK异常表达是肝小叶结构修复过程中局部肝细胞的修复性反应这一假说的有力支持。讨论了这种改变的意义。  相似文献   

6.
本研究用免疫组化结合图像分析观测了针刺对切除一侧L1-S2背根(保留L6背根)猫脊髓L5Ⅱ板层内含P物质(SP)、胆囊收缩素(CCK),亮氨酸脑啡肽(L-ENK)和5-羟色胺(5-HT)神经纤维可塑性的影响。结果如下:非针刺组手术侧Ⅱ板层SP和CCK阳性面积分别为非手术侧的77%和46%,而针刺组手术侧SP已恢复到非手术侧水平,CCK为非手术侧的66%,均比非针刺组明显增加。术后30天再切断L6备用根后两组动物手术侧SP和CCK阳性面积显著下降,表明针刺促进备用根中SP和CCK神经纤维发生可塑变化;手术切断背根上L-ENK阳性面积无影响,而针刺后有所增加,表明针刺能影响中间神经元的L-ENK神经纤维发生可塑性变化;背根切断后下行投射的5-HT阳性面积明显增加,而针刺无进一步促进作用。  相似文献   

7.
为研究庚型肝炎病毒在福州地区的重叠感染,采用ELISA法检测本院住院的286例病毒性肝炎(HV)患者和500名供血员的抗-HGV。结果表明,甲、乙、丙、戊型肝炎患者和供血员的抗-HGV检出率分别为2.0%、2.2%、4.0%、10.0%和0.2%。急性肝炎、慢性肝炎、慢性重型肝炎、肝硬化、原发性肝癌和抗-HCV阳性供血员的检出率分别为7.9%、4.3%、33.3%、0%、7.1%和6.3%,慢性重型肝炎检出率较慢性肝炎显著升高(P<0.05)。各型肝炎患者和供血员均存在庚型肝炎病毒重叠感染,以慢性重型肝炎为著。  相似文献   

8.
重组人蛋白激酶CK2β亚基cDNA的克隆与测序   总被引:27,自引:0,他引:27  
蛋白激酶CK2是一种存在的信使非依赖性丝/苏氨酸蛋白激酶.它是由两个催化亚基(α或α′)和两个调节亚基(β)组成的不均一四聚体.用反转录PCR从HL-60细胞中获得了人蛋白激酶CK2β亚基编码区cDNA,将NdeⅠ/HindⅢ双酶切PCR产物连接到表达载体pT7-7的NdeⅠ/HindⅢ双酶切位点中.转化感受态细菌DH5α获得转化子,阳性筛选率为72%.限制性酶切分析结果表明,插入片段和重组质粒的大小与理论推测值相符.随机挑选4个阳性质粒测定其插入片段DNA序列,结果显示有2个含有正确插入的人蛋白激酶CK2βcDNA,命名为pTCKB.其余2个克隆分别存在1个和2个点突变,即在其编码区condon148的TCA→TTA,结果Ser→Leu;另一个则在Condon143GTG→ATG,Val→Met;Condon170GTG→GCG,Val→Ala.重组质粒(pTCKB)克隆的成功,将为在原核细胞中表达蛋白激酶CK2β亚基以及利用CK2βcDNA作为探针进行深入研究打下基础.并为利用pT7-7表达载体构建其他重组质粒建立了一套成功的方法  相似文献   

9.
通过硫酸铵分级沉淀、CM-52阳离子交换层析、HRLC分子排阻层析及FPLCMonoS离子交换层析等步骤,从丝瓜籽中分离到一组分子量为8kD左右的小分子核糖体失活蛋白——LufinS1、LufinS2、LufinS3。末端分析结果表明,它们的N端氨基酸分别为Ala、Pro和Thr。氨基酸序列分析确定了LufinS2的N端9个氨基酸的序列是Pro-Arg-Arg-Gly-Gln-Glu-Ala-Phe-Asp。LufinSs对核糖体的失活机制与天花粉蛋白(TCS)一致,是RNAN-糖苷酶催化型的。它们对无细胞蛋白质生物合成的抑制活性较TCS略强,IC50分别为1.3×10-11、1.0×10-10和6.3×10-11mol/L左右。因此LufinSs有可能开发成免疫毒素的高效“弹头”。  相似文献   

10.
人肝刺激因子对大鼠实验性慢性肝损伤的保护作用   总被引:3,自引:0,他引:3  
从健康孕妇水囊引产4─6个月龄的胎儿取肝,采用LaBrecque方法提取人肝刺激因子(hHSS)。经3H-胸腺嘧啶核苷参入肝DNA法测定其生物活性。表明此hHSS可刺激肝细胞DNA合成。采用皮下注射CCl4和饮用10%乙醇来制备慢性肝损伤动物模型,观察了hHSS的保护肝脏作用。结果表明:hHSS可使CCl4-乙醇所致慢性肝损伤大鼠的死亡率、血清谷丙转氨酶水平、肝组织中羟脯氨酸含量的升高以及肝组织中丙二醛的含量降低。肝组织切片表明:hHSS能减轻肝组织的损伤程度,促进肝细胞再生,并能明显防止肝纤维化的形成和发展。可见,hHSS对CCl4-乙醇所致的慢性肝损伤大鼠有明显的保护作用,其机制可能与促进肝细胞再生及抑制肝细胞膜的脂质过氧化有关。  相似文献   

11.
12.
It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.  相似文献   

13.
14.
15.
正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases  相似文献   

16.
Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.  相似文献   

17.
18.
19.
Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.  相似文献   

20.
Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号